Consensus on the management of patients with psoriatic arthritis in a dermatology setting

J Eur Acad Dermatol Venereol. 2018 Apr;32(4):515-528. doi: 10.1111/jdv.14741. Epub 2018 Jan 11.

Abstract

Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis (PsO). Early diagnosis and prompt therapeutic intervention are crucial for limiting PsA progression and prevention of disability. Dermatologists are in a privileged position to detect early PsA. The management of patients with PsA in the dermatology setting is widely variable.

Objective: To provide practical recommendations for the management of patients with PsA in the dermatology setting including early diagnosis and treatment.

Methods: A consensus document was written by an expert panel composed by dermatologists (n = 12) and rheumatologists (n = 6). Eleven highly relevant questions were selected and elaborated with answers/statements based on a narrative literature review. The resulting document was discussed in a face-to-face meeting adopting a nominal group technique to reach consensus (i.e. 100% agreement) using the Delphi method.

Results: A consensus was achieved in defining the following: the clinical characteristics differentiating inflammatory and non-inflammatory signs and symptoms of joint disease; the most important differential diagnoses of PsA in clinical practice; the most useful screening questionnaires, serum laboratory tests and imaging techniques for the detection of early PsA; the criteria for dermatologist to refer patients with PsO to rheumatologist; the criteria for the diagnosis of PsA; the selection of the indices that the dermatologist could use for measuring the activity and severity of PsA in clinical practice; when systemic steroids and/or intra-articular steroid injections are indicated in the treatment of PsA. Finally, systemic treatments including synthetic and biologic disease-modifying antirheumatic drugs to be considered for the treatment of PsA have been reported.

Conclusions: The implementations of these practical recommendations could be very helpful for the management of patients with PsA in the dermatology setting including early diagnosis and treatment.

Publication types

  • Consensus Development Conference

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use
  • Arthritis, Psoriatic / diagnosis*
  • Arthritis, Psoriatic / physiopathology
  • Arthritis, Psoriatic / therapy*
  • Clinical Laboratory Techniques
  • Delphi Technique
  • Dermatologists
  • Early Diagnosis
  • Humans
  • Inflammation / physiopathology
  • Injections, Intra-Articular
  • Practice Guidelines as Topic
  • Referral and Consultation
  • Rheumatologists
  • Severity of Illness Index
  • Surveys and Questionnaires

Substances

  • Adrenal Cortex Hormones